Fenofibrate
Category: Health and Fitness » Medicine
Fenofibrate is a drug of the fibrate class. Fenofibrate was developed near Groupe Fournier SA, previous it was acquired in 2005 by Solvay Pharmaceutical, a subject section owned by the Belgian corporation, Solvay S.A. In 2009 Solvay Pharmaceutical was acquired sooner than Abbott Laboratories. It is above all occupied to restrict cholesterol levels in patients at jeopardize of cardiovascular disease. Like other fibrates, it reduces both low-density lipoprotein (LDL) and terribly unrefined density lipoprotein (VLDL) levels, as favourably as increasing high-density lipoprotein (HDL) levels and reducing triglycerides level. It also appears to have a useful effect on the insulin resistance featured by way of the metabolic syndrome.<>] It is used alone or in conjunction with statins in the treatment of hypercholesterolemia and hypertriglyceridemia.
Dosage
The pharmaceutical ceremony and the strength may switch from one-liner country to another, and from everybody label to another. In the Joint States, Tricor was reformulated in 2005 and is available in tablets of 48 and 145 mg. This reformulation is unsettled, as it is seen as an attempt to silence contention from generic equivalents of the soporific,<>] and is the theme of antitrust lawsuit next to generic medicine industrialist Teva.<>] Also convenient in the United States, Lofibra is available in 54 and 160 mg tablets, as well-head as 67, 134, and 200 mg micronized capsules.<>] Generic equivalents of Lofibra capsules are currently convenient in all three strengths in the Allied States. In Europe, it is available in either coated tombstone or capsule; the persuasiveness distribute includes 67, 145, 160 and 200 mg. The differences in the midst strengths are a result of altered bioavailability (the fraction immersed by the body) due to jot size. For model, 200 mg can be replaced by 160 mg micronized fenofibrate. The 145 mg tricor online talent is a rejuvenated strength that appeared in 2005-2006 which also replaces 200 or 160 mg as the fenofibrate is nanonised (i.e. the particle size is cheaper than 400 nm).
Fenofibrate increases the serum parallel of statins. As a result, a belittle measure of statin is normally necessary. Dispense of fenofibrate be required to also be lowered in steady to serious renal failure and most experts counsel that fenofibrate be gospel in the morning and the statin at night.
Fenofibrate is a fibric acid acquired whose lipid modifying effects reported in humans are mediated via activation of peroxisome proliferator-activated receptor paradigm alpha (PPARa). Wholly activation of PPARa fenofibrate increases the lipolysis and elimination of atherogenic triglyceride-rich particles from plasma by activating lipoprotein lipase and reducing construction of apoprotein CIII. Activation of PPARa also induces an increasing in the synthesis of apoproteins AI and AII, which leads to a reduction in very low- and low-density fractions (VLDL and LDL) containing apoprotein B and an improve in the high-density lipoprotein fraction (HDL) containing apoprotein AI and AII. In joining, via modulation of the composite and catabolism of VLDL fractions, fenofibrate increases the LDL space and reduces small and stupid LDL, the levels of which are illustrious in the atherogenic lipoprotein phenotype, a common rumpus in patients at risk for coronary heart disease.<>]
Fenofibrate is second-line therapy recompense hypercholesterolaemia and hypertriglyceridaemia by oneself or combined (types IIa, IIb, III, IV and V dyslipidaemias)<>], in situations in which outset borderline psychotherapy is too little or has improper side-effects.
Fenofibrate is contra-indicated in children, during pregnancy or lactation, in patients with liver insufficiency, self-possession of gallstones, renal insufficiency, in patients hypersensitive to fenofibrate and/or excipients, known photoallergy or phototoxic counteraction during treatment with fibrates or ketoprofen.
Three randomized, double-blind, multicenter, phase III trials obtain shown that treatment with fenofibric acid extra a statin (atorvastatin, rosuvastatin or simvastatin) improved HDL and triglyceride levels significantly improved than statin monotherapy and improved LDL levels heartier than fenofibric acid monotherapy.<>]
The Fenofibrate Intervention and Circumstance Lowering in Diabetes (BATTLEFIELD) study, which is the largest fibrate lawsuit involving 9795 patients with type 2 diabetes mellitus published in 2005 did not show a significantly let risk in behalf of the elementary goal point (non-fatal myocardial infarction and coronary basic nature disorder downfall). But, it did report a relevant endanger reduction of 11% for Non-Fatal MI & CHD, although statistically insignificant. The spare end-point (comprehensive cardiovascular condition events) was statistically significant with a analogous to hazard reduction of 11% in the direction of total CVD events. There was a overweight measurements of placebo patients who commenced engaging statin drugs during the sample, which in put out force strike the results of the study itself. After an to rights was done quest of this statin plummet in, the subordinate to jeopardy reductions were 19% for Non-Fatal MI & CHD Decease, and 15% suited for compute CVD events.<>]
The AREA study also showed a favourable reduction in the gamble of microvascular complications in species 2 diabetes patients. Fenofibrate treatment led to reduction in the course albuminuria (14% less advancement and 15% more regression compared with placebo). In appendix, there was a 30% reduction in the needs after laser treatment for retinopathy.<>]
The BUFF sub-study division, shows that fenofibrate reduces the foremost laser treatment past 31%. In appendage, throughout macular oedema by 31% and since proliferative retinopathy by 30%.<>] In the ophthalmology sub-study, fenofibrate reduces the growth or sequence of retinopathy away reducing 22% in all patients and 79% in patients with pre-existing retinopathy.<>]
The FIELD burn the midnight oil also showed that fenofibrate reduced the few of non-traumatic amputations next to 38%.<>]
Like most fibrates, fenofibrate can cause belly upsets and myopathy (muscle trouble) and very seldom rhabdomyolysis. This imperil is increased when reach-me-down together with statins. But, the Fenofibrate Intervention and Result Lowering in Diabetes (SWARD) about provides impressive bumf that long-term treatment with fenofibrate remedial programme appears to play a joke on a favorable security limn gross in patients with breed 2 diabetes, disinterested when nonstudy lipid-lowering medications were added. In FIELD, there were no cases of rhabdomyolysis reported in patients on combination therapy with fenofibrate and a statin. Way, there is an increasing body of substantiation that fenofibrate/statin combination remedy is sheltered and productive at managing dyslipidemia in patients with type 2 diabetes who are at risk in behalf of cardiovascular events. The BE AT ONE memorize, in whatever way, does not forward the unaffected by affirmation with regard to effectiveness (inquire about bid adieu beneath).
The recent AREA Sub-analysis reflect on published in Diabetes Nurse b like 2009, showed that fenofibrate significantly reduced CVD events in those with inadequate HDL cholesterol and hypertension. The largest essence of fenofibrate to lose weight CVD endanger was observed in subjects with prominent dyslipidemia (TG>2.3 mmol/L & inferior HDL-C) in whom a 27% proportionate reduction chance of comprehensive CVD end was observed. Some obtain argued that the utter benefits of fenofibrate are meet to be greater when metabolic syndrome features are present. The highest chance and greatest benefits of fenofibrate are seen among those with significant hypertriglyceridemia<>0], in any case these conclusions are not based on the ordained endpoints of the analysis in the revealing powerful group.
Immortal markers of macrovascular and microvascular risk were associated with degrade margin amputations in patients with prototype 2 diabetes. Treatment with fenofibrate was associated with a diminish hazard of amputations, particularly lesser amputations without known large-vessel disability, undoubtedly through non-lipid mechanisms. These findings could assume command of to a alteration in yardstick treatment for the inhibiting of diabetes-related lower-limb amputations.<>1]
In 2010, the Exercise to Device Cardiovascular Risk in Diabetes (UNANIMITY) inquiry showed that fenofibrate advantage statins in patients with kind 2 diabetes does not crop cardiovascular events more than utilize of statins alone.<>2] The CONCERT enrolled 5518 patients and followed them up looking for 4.7 years, providing to some extent steadfast evince for lack of valid moving spirit further for using fibrates in diabetic patients with inebriated cholesterol.
Gastrointestinal: Digestive, gastric or intestinal disorders (abdominal agony, nausea, vomiting, diarrhea, and flatulence). Rind Reactions: Rashes, Pruritus, urticaria or photosensitivity reactions.
Fenofibrate has a uricosuric secure, making it of take in the management of gout.<>3] It also acts as a blood thinner nearby lowering the amount of fibrinogen in the blood.<>4]
Fenofibrate exhibits anticonvulsant properties comparable to the Ketogenic Intake in adult rats, using pentylenetetrazol and lithium-pilocarpine models <>5]
Fenofibrate is sold directed the brand esteem Tricor and Trilipix at hand Abbott Labs, Lipofen by Kowa Pharmaceuticals America Inc, Lofibra on Teva, Lipanthyl, Lipidil, and Supralip not later than Solvay Pharmaceutical, Fenocor-67 next to Ordain Healthiness Take care of, Fenogal alongside SMB Laboratories, Antara at near Oscient Pharmaceuticals, and Golip not later than GolgiUSA.
Dosage
The pharmaceutical ceremony and the strength may switch from one-liner country to another, and from everybody label to another. In the Joint States, Tricor was reformulated in 2005 and is available in tablets of 48 and 145 mg. This reformulation is unsettled, as it is seen as an attempt to silence contention from generic equivalents of the soporific,<>] and is the theme of antitrust lawsuit next to generic medicine industrialist Teva.<>] Also convenient in the United States, Lofibra is available in 54 and 160 mg tablets, as well-head as 67, 134, and 200 mg micronized capsules.<>] Generic equivalents of Lofibra capsules are currently convenient in all three strengths in the Allied States. In Europe, it is available in either coated tombstone or capsule; the persuasiveness distribute includes 67, 145, 160 and 200 mg. The differences in the midst strengths are a result of altered bioavailability (the fraction immersed by the body) due to jot size. For model, 200 mg can be replaced by 160 mg micronized fenofibrate. The 145 mg tricor online talent is a rejuvenated strength that appeared in 2005-2006 which also replaces 200 or 160 mg as the fenofibrate is nanonised (i.e. the particle size is cheaper than 400 nm).
Fenofibrate increases the serum parallel of statins. As a result, a belittle measure of statin is normally necessary. Dispense of fenofibrate be required to also be lowered in steady to serious renal failure and most experts counsel that fenofibrate be gospel in the morning and the statin at night.
Fenofibrate is a fibric acid acquired whose lipid modifying effects reported in humans are mediated via activation of peroxisome proliferator-activated receptor paradigm alpha (PPARa). Wholly activation of PPARa fenofibrate increases the lipolysis and elimination of atherogenic triglyceride-rich particles from plasma by activating lipoprotein lipase and reducing construction of apoprotein CIII. Activation of PPARa also induces an increasing in the synthesis of apoproteins AI and AII, which leads to a reduction in very low- and low-density fractions (VLDL and LDL) containing apoprotein B and an improve in the high-density lipoprotein fraction (HDL) containing apoprotein AI and AII. In joining, via modulation of the composite and catabolism of VLDL fractions, fenofibrate increases the LDL space and reduces small and stupid LDL, the levels of which are illustrious in the atherogenic lipoprotein phenotype, a common rumpus in patients at risk for coronary heart disease.<>]
Fenofibrate is second-line therapy recompense hypercholesterolaemia and hypertriglyceridaemia by oneself or combined (types IIa, IIb, III, IV and V dyslipidaemias)<>], in situations in which outset borderline psychotherapy is too little or has improper side-effects.
Fenofibrate is contra-indicated in children, during pregnancy or lactation, in patients with liver insufficiency, self-possession of gallstones, renal insufficiency, in patients hypersensitive to fenofibrate and/or excipients, known photoallergy or phototoxic counteraction during treatment with fibrates or ketoprofen.
Three randomized, double-blind, multicenter, phase III trials obtain shown that treatment with fenofibric acid extra a statin (atorvastatin, rosuvastatin or simvastatin) improved HDL and triglyceride levels significantly improved than statin monotherapy and improved LDL levels heartier than fenofibric acid monotherapy.<>]
The Fenofibrate Intervention and Circumstance Lowering in Diabetes (BATTLEFIELD) study, which is the largest fibrate lawsuit involving 9795 patients with type 2 diabetes mellitus published in 2005 did not show a significantly let risk in behalf of the elementary goal point (non-fatal myocardial infarction and coronary basic nature disorder downfall). But, it did report a relevant endanger reduction of 11% for Non-Fatal MI & CHD, although statistically insignificant. The spare end-point (comprehensive cardiovascular condition events) was statistically significant with a analogous to hazard reduction of 11% in the direction of total CVD events. There was a overweight measurements of placebo patients who commenced engaging statin drugs during the sample, which in put out force strike the results of the study itself. After an to rights was done quest of this statin plummet in, the subordinate to jeopardy reductions were 19% for Non-Fatal MI & CHD Decease, and 15% suited for compute CVD events.<>]
The AREA study also showed a favourable reduction in the gamble of microvascular complications in species 2 diabetes patients. Fenofibrate treatment led to reduction in the course albuminuria (14% less advancement and 15% more regression compared with placebo). In appendix, there was a 30% reduction in the needs after laser treatment for retinopathy.<>]
The BUFF sub-study division, shows that fenofibrate reduces the foremost laser treatment past 31%. In appendage, throughout macular oedema by 31% and since proliferative retinopathy by 30%.<>] In the ophthalmology sub-study, fenofibrate reduces the growth or sequence of retinopathy away reducing 22% in all patients and 79% in patients with pre-existing retinopathy.<>]
The FIELD burn the midnight oil also showed that fenofibrate reduced the few of non-traumatic amputations next to 38%.<>]
Like most fibrates, fenofibrate can cause belly upsets and myopathy (muscle trouble) and very seldom rhabdomyolysis. This imperil is increased when reach-me-down together with statins. But, the Fenofibrate Intervention and Result Lowering in Diabetes (SWARD) about provides impressive bumf that long-term treatment with fenofibrate remedial programme appears to play a joke on a favorable security limn gross in patients with breed 2 diabetes, disinterested when nonstudy lipid-lowering medications were added. In FIELD, there were no cases of rhabdomyolysis reported in patients on combination therapy with fenofibrate and a statin. Way, there is an increasing body of substantiation that fenofibrate/statin combination remedy is sheltered and productive at managing dyslipidemia in patients with type 2 diabetes who are at risk in behalf of cardiovascular events. The BE AT ONE memorize, in whatever way, does not forward the unaffected by affirmation with regard to effectiveness (inquire about bid adieu beneath).
The recent AREA Sub-analysis reflect on published in Diabetes Nurse b like 2009, showed that fenofibrate significantly reduced CVD events in those with inadequate HDL cholesterol and hypertension. The largest essence of fenofibrate to lose weight CVD endanger was observed in subjects with prominent dyslipidemia (TG>2.3 mmol/L & inferior HDL-C) in whom a 27% proportionate reduction chance of comprehensive CVD end was observed. Some obtain argued that the utter benefits of fenofibrate are meet to be greater when metabolic syndrome features are present. The highest chance and greatest benefits of fenofibrate are seen among those with significant hypertriglyceridemia<>0], in any case these conclusions are not based on the ordained endpoints of the analysis in the revealing powerful group.
Immortal markers of macrovascular and microvascular risk were associated with degrade margin amputations in patients with prototype 2 diabetes. Treatment with fenofibrate was associated with a diminish hazard of amputations, particularly lesser amputations without known large-vessel disability, undoubtedly through non-lipid mechanisms. These findings could assume command of to a alteration in yardstick treatment for the inhibiting of diabetes-related lower-limb amputations.<>1]
In 2010, the Exercise to Device Cardiovascular Risk in Diabetes (UNANIMITY) inquiry showed that fenofibrate advantage statins in patients with kind 2 diabetes does not crop cardiovascular events more than utilize of statins alone.<>2] The CONCERT enrolled 5518 patients and followed them up looking for 4.7 years, providing to some extent steadfast evince for lack of valid moving spirit further for using fibrates in diabetic patients with inebriated cholesterol.
Gastrointestinal: Digestive, gastric or intestinal disorders (abdominal agony, nausea, vomiting, diarrhea, and flatulence). Rind Reactions: Rashes, Pruritus, urticaria or photosensitivity reactions.
Fenofibrate has a uricosuric secure, making it of take in the management of gout.<>3] It also acts as a blood thinner nearby lowering the amount of fibrinogen in the blood.<>4]
Fenofibrate exhibits anticonvulsant properties comparable to the Ketogenic Intake in adult rats, using pentylenetetrazol and lithium-pilocarpine models <>5]
Fenofibrate is sold directed the brand esteem Tricor and Trilipix at hand Abbott Labs, Lipofen by Kowa Pharmaceuticals America Inc, Lofibra on Teva, Lipanthyl, Lipidil, and Supralip not later than Solvay Pharmaceutical, Fenocor-67 next to Ordain Healthiness Take care of, Fenogal alongside SMB Laboratories, Antara at near Oscient Pharmaceuticals, and Golip not later than GolgiUSA.